Accordingly, IDH mutant non-Codel DNA methylation signatures allowed the segregation of LGG-GBM G-CIMP tumors into two discrete disease subtypes independent of neuropathological grading (G-CIMP-high and G-CIMP-low). The gene discussed is IDH2; the disease is glioblastoma.